Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Isoproterenol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 6/20 | 0.85 |
| ▸ | ADRB1 known ✓ | P08588 | 4/20 | 0.85 |
| ▸ | ADRB3 known ✓ | P13945 | 4/20 | 0.85 |
| ▸ | MAPT | P10636 | 7/20 | 0.85 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.85 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.85 |
| ▸ | MEN1 | O00255 | 5/20 | 0.85 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.85 |
| ▸ | TSHR | P16473 | 4/20 | 0.85 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.85 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.85 |
| ▸ | MTOR | P42345 | 3/20 | 0.85 |
| ▸ | LMNA | P02545 | 3/20 | 0.85 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.85 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.85 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.85 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.85 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.85 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.85 |
| ▸ | DRD2 | P14416 | 2/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isoproterenol SCHEMBL5682034 | 0.98 | MAPT (0.82) | MAPTADRB2TDP1KDM4EMEN1 | |
| Isoproterenol SCHEMBL7268328 | 0.97 | ADRB2 (0.85) | MAPTADRB2TDP1KDM4EMEN1 | |
| Isoproterenol SCHEMBL582812 | 0.95 | ADRB2 (0.85) | MAPTADRB2TDP1KDM4EMEN1 | |
| Metaproterenol SCHEMBL9051746 | 0.93 | BLM (0.79) | MAPTADRB2TDP1KDM4EMEN1 | |
| Isoproterenol SCHEMBL29519146 | 0.92 | MAPT (1.00) | MAPTADRB2TDP1KDM4EMEN1 | |
| Isoproterenol SCHEMBL29386243 | 0.92 | MAPT (1.00) | MAPTADRB2TDP1KDM4EMEN1 | |
| Levisoprenaline SCHEMBL250806 | 0.92 | MAPT (1.00) | MAPTADRB2TDP1KDM4EMEN1 | |
| Levisoprenaline SCHEMBL29620666 | 0.92 | MAPT (1.00) | MAPTADRB2TDP1KDM4EMEN1 | |
| Isoproterenol SCHEMBL4166 | 0.92 | MAPT (1.00) | MAPTADRB2TDP1KDM4EMEN1 | |
| Isoproterenol SCHEMBL4165 | 0.92 | MAPT (1.00) | MAPTADRB2TDP1KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1796 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114053206-A | Medicinal floating preparation and preparation method thereof | 常州恒邦药业有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-114053207-A | Sustained-release pharmaceutical composition and preparation method thereof | 常州恒邦药业有限公司 | 2022-02-18 | — | — | CN | claimed |
| US-20220008334-A1 | GASTRIC RETENTIVE DEVICES | CLEXIO BIOSCIENCES LTD. (IL) | 2022-01-13 | — | — | US | claimed |
| US-11147766-B2 | Gastric retentive devices | CLEXIO BIOSCIENCES LTD. (IL) | 2021-10-19 | — | — | US | claimed |
| WO-2018087779-A1 | TRANSDERMAL DELIVERY SYSTEM AND SPRAY-DEVICE | CIPLA LIMITED (IN) | 2018-05-17 | — | — | WO | claimed |
| CN-107382750-A | A kind of preparation method of isoproterenol sulfate | 山东科源制药股份有限公司 | 2017-11-24 | — | — | CN | claimed |
| CN-107011187-A | A kind of preparation method of isoproterenol sulfate dihydrate | 山东科源制药股份有限公司 | 2017-08-04 | — | — | CN | claimed |
| US-9649093-B2 | Cavity-filling biopsy site markers | SENORX, INC. (US) | 2017-05-16 | — | — | US | claimed |
| US-20160120510-A1 | CAVITY-FILLING BIOPSY SITE MARKERS | SENORX, INC. | 2016-05-05 | — | — | US | claimed |
| US-7500479-B2 | Aerosol generators and methods for producing aerosols | PHILIP MORRIS USA INC. (US) | 2009-03-10 | — | — | US | claimed |
| EP-0455463-B1 | Packaging for microdoses of powdered medicament for inhalation | RIKER LABORATORIES INC (US) | 1994-12-07 | — | — | EP | claimed |
| EP-0536204-B1 | THE USE OF SOLUBLE FLUOROSURFACTANTS FOR THE PREPARATION OF METERED-DOSE AEROSOL FORMULATIONS | MINNESOTA MINING & MFG (US) | 1994-04-06 | — | — | EP | claimed |
| EP-0536204-A1 | THE USE OF SOLUBLE FLUOROSURFACTANTS FOR THE PREPARATION OF METERED-DOSE AEROSOL FORMULATIONS. | MINNESOTA MINING & MFG (US) | 1993-04-14 | — | — | EP | claimed |
| US-5192548-A | DEVICE | RIKER LABORATOIRES, INC. (US) | 1993-03-09 | — | — | US | claimed |
| WO-1992000062-A1 | THE USE OF SOLUBLE FLUOROSURFACTANTS FOR THE PREPARATION OF METERED-DOSE AEROSOL FORMULATIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-01-09 | — | — | WO | claimed |
| EP-0455463-A1 | Packaging for microdoses of powdered medicament for inhalation | RIKER LABORATORIES, INC. (US) | 1991-11-06 | — | — | EP | claimed |
| US-5023088-A | Drug delivery dispenser | ALZA CORPORATION (US) | 1991-06-11 | — | — | US | claimed |
| EP-0145209-B1 | A KIT OR DEVICE AND METHOD FOR ADMINISTERING GANGLIOSIDES AND DERIVATIVES THEREOF OF INHALATION AND PHARMACEUTICAL COMPOSITIONS SUITABLE THEREFOR | FIDIA S.p.A. (IT) | 1989-10-11 | — | — | EP | claimed |
| US-4352789-A | COATING OF PERFLUORINATED SURFACTANT; INHALANTS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1982-10-05 | — | — | US | claimed |
| US-4038417-A | ADRENERGIC STIMULATING AGENTS, ISOPROTERENOL | NELSON RESEARCH & DEVELOPMENT COMPANY (US) | 1977-07-26 | — | — | US | claimed |